| Serial Number | 99007760 |
| Word Mark | XTURNPOINT |
| Filing Date | Friday, January 17, 2025 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, April 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, February 24, 2026 |
| Goods and Services | Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics |
| Pseudo Mark | X TURN POINT |
| Goods and Services | Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics |
| Description of Mark | The mark consists of a black rectangle having a stylized letter "X" within the left side of its interior, which appears in the colors blue, purple, green, and orange. To the right of this stylized, multicolor letter "X" the black rectangle has portions cut out of it, resembling how a stencil creates a silhouette of the shapes cut from its interior. Here, the portions missing from, or cut out of, the mark's black rectangle correspond with the outline of stylized wording that spells "TURNPOINT". The enclosed white spaces appearing in the mark drawing are transparent areas, reflecting background only, and are not being claimed as a feature of the mark. |
| Goods and Services | Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics |
| Indication of Colors claimed | The colors black, blue, purple, orange, and green are claimed as a feature of the mark. |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Xentria, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60631 US |
| Party Name | Xentria, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60631 US |
| Event Date | Event Description |
| Friday, January 17, 2025 | NEW APPLICATION ENTERED |
| Sunday, June 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 27, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, July 8, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 8, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 8, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 8, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 26, 2025 | FINAL REFUSAL WRITTEN |
| Wednesday, November 26, 2025 | FINAL REFUSAL E-MAILED |
| Wednesday, November 26, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, January 29, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 29, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 29, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 29, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, January 30, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 18, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 24, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 24, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 21, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |